Registry for transcatheter valve treatments in heart valve diseases

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This registry assesses the feasibility, safety, and outcomes of transcatheter valve interventions for patients with heart valve diseases. It aims to describe the patient populations selected for these treatments, procedural aspects, and clinical outcomes following the interventions. The study will also monitor hemodynamic outcomes and quality of life parameters, providing valuable data to tailor treatment indications in this evolving field of interventional cardiology. The design is prospective and non-interventional, focusing on real-world patient experiences.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* All patients selected for percutaneous treatment of a valve disorder potentially qualify for the present registry

Exclusion Criteria:

* All patients selected for percutaneous treatment of a valve disorder potentially qualify for the present registry. There are no formal exclusion criteria.

Where it's running

• Department of Cardiology, University Hospital Gasthuisberg
  Leuven, Belgium Recruiting

Study contacts

• Study coordinator: Christophe Dubois, MD, PhD
• Email: christophe.dubois@uzleuven.be

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Transcatheter Tricuspid Valve Replacement for Severe Tricuspid Regurgitation

  This trial tests the Laplace TTVR System to see if it safely and effectively treats adults with severe tricuspid regurgitation.

  Recruiting at 2 sites Laplace Interventional, Inc · Tulsa, Oklahoma and 1 other locations · NCT07687485

• TRIFORMIS RESILIA heart valve real-world results in tricuspid disease

  A real-world, observational study to see how the Edwards TRIFORMIS RESILIA tricuspid heart valve performs in adults needing tricuspid valve replacement.

  Recruiting Edwards Lifesciences · Carmel, Indiana · NCT07684313

• Multimodal Cardiac MRI to See How the Heart Is Working

  This study tests a comprehensive MRI approach to characterize heart structure and tissue in adults with suspected or confirmed cardiovascular disease.

  Recruiting Second Affiliated Hospital, Zhejiang University, School of Medicine · Hangzhou, Zhejiang · NCT07617844

• Portable electronic stethoscope and machine-learning detection of heart valve disease

  We will test whether a portable electronic stethoscope combined with a machine-learning algorithm can accurately detect valvular heart disease in people with known valve problems and in healthy volunteers.

  Recruiting The University of Hong Kong · Hong Kong, Pok Fu Lam Rd. · NCT07568795

• Vyne TriNova Transcatheter Tricuspid Valve Replacement study for severe tricuspid regurgitation

  This trial tests the VDyne TriNova system in adults with symptomatic severe tricuspid regurgitation to see if it is safe and helps heart symptoms compared with an alternative device.

  Recruiting at 12 sites VDyne, Inc. · Phoenix, Arizona and 11 other locations · NCT07516444

• AI-assisted screening for heart valve disease using routine non-contrast chest CT

  This will test whether an AI program can spot moderate-to-severe heart valve disease on routine non-contrast chest CT scans in adults.

  Recruiting at 3 sites Second Affiliated Hospital, Zhejiang University, School of Medicine · Wuhan, Hubei and 2 other locations · NCT07449130

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.